Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Wino115on Dec 05, 2022 9:14am
196 Views
Post# 35150655

RE:Wierd

RE:Wierd

For what it's worth, IR said there were systemwide newswire glitches when they went to release.That's why they used NASDAQ filing  as a backup until PR firm fixed their issue. I've noticed new IR and PR women have been more consistent in getting news on more platforms. Not a bad thing to do.

On another note, there still appear to be a lot of followers up here as my post got around 300 reads. Guess there's more interested ears we never knew about. 


SABBOBCAT wrote: So you'd think woth disappointing news you'd do the late evening PR late on the week to do it as quietly as possible. While TH did the late night thing, they didn't do it quietly and blasted it across every social media account on English and French. Something seems off about the whole situation and strategy here. 

 

<< Previous
Bullboard Posts
Next >>